HK1037978A1 - Vaccine against sexually transmitted diseases - Google Patents

Vaccine against sexually transmitted diseases

Info

Publication number
HK1037978A1
HK1037978A1 HK01108911A HK01108911A HK1037978A1 HK 1037978 A1 HK1037978 A1 HK 1037978A1 HK 01108911 A HK01108911 A HK 01108911A HK 01108911 A HK01108911 A HK 01108911A HK 1037978 A1 HK1037978 A1 HK 1037978A1
Authority
HK
Hong Kong
Prior art keywords
vaccine against
sexually transmitted
transmitted diseases
against sexually
diseases
Prior art date
Application number
HK01108911A
Other languages
English (en)
Inventor
Moncef Mohamed Slaoui
Pierre G Vandepapeliere
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1037978(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of HK1037978A1 publication Critical patent/HK1037978A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK01108911A 1998-09-11 2001-12-19 Vaccine against sexually transmitted diseases HK1037978A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use
PCT/EP1999/006623 WO2000015255A1 (fr) 1998-09-11 1999-09-08 Vaccin contre les maladies sexuellement transmissibles

Publications (1)

Publication Number Publication Date
HK1037978A1 true HK1037978A1 (en) 2002-03-01

Family

ID=10838766

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108911A HK1037978A1 (en) 1998-09-11 2001-12-19 Vaccine against sexually transmitted diseases

Country Status (29)

Country Link
EP (1) EP1109574B1 (fr)
JP (1) JP2002524532A (fr)
KR (1) KR100777896B1 (fr)
CN (2) CN101130070A (fr)
AR (1) AR021798A1 (fr)
AT (1) ATE392214T1 (fr)
AU (1) AU744989B2 (fr)
BR (1) BR9913630A (fr)
CA (1) CA2343399C (fr)
CO (1) CO5090882A1 (fr)
CY (1) CY1108147T1 (fr)
CZ (1) CZ302808B6 (fr)
DE (1) DE69938555T2 (fr)
DK (1) DK1109574T3 (fr)
ES (1) ES2304068T3 (fr)
GB (1) GB9819898D0 (fr)
HK (1) HK1037978A1 (fr)
HU (1) HUP0104297A3 (fr)
IL (1) IL141843A0 (fr)
MY (1) MY122216A (fr)
NO (1) NO329522B1 (fr)
NZ (1) NZ510425A (fr)
PL (1) PL199545B1 (fr)
PT (1) PT1109574E (fr)
SI (1) SI1109574T1 (fr)
TR (1) TR200100948T2 (fr)
TW (1) TWI225790B (fr)
WO (1) WO2000015255A1 (fr)
ZA (1) ZA200101987B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69935606T9 (de) 1998-10-16 2021-03-11 Glaxosmithkline Biologicals S.A. Adjuvanzsysteme und impfstoffe
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
WO2007081447A2 (fr) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Antigènes de norovirus et de sapovirus
CA2637598A1 (fr) 2006-01-18 2007-02-14 University Of Chicago Compositions et procedes se rapportant a des proteines de bacteries staphylococciques
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Gas57 돌연변이 항원 및 gas57 항체
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
US8585505B2 (en) 2008-12-15 2013-11-19 Tetris Online, Inc. Inter-game interactive hybrid asynchronous computer game infrastructure
ES2596653T3 (es) 2009-06-16 2017-01-11 Glaxosmithkline Biologicals Sa Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento
WO2011026111A1 (fr) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Distribution par voie orale d'un vaccin au gros intestin pour induire une immunité mucosale
AU2011237393B2 (en) 2010-04-08 2015-01-22 University Of Pittsburgh - Of The Commonwealth System Of Higher Education B-cell antigen presenting cell assay
JP6109165B2 (ja) * 2011-07-01 2017-04-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ヘルペスウイルスワクチンおよび使用方法
SG11201700061PA (en) 2014-07-07 2017-02-27 Prophylaxis LLC Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
CA3010905A1 (fr) 2016-02-22 2017-08-31 Boehringer Ingelheim Vetmedica Gmbh Procede d'immobilisation de biomolecules
WO2020086408A1 (fr) 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bioprocédé d'expression génique transitoire basé sur une perfusion à haut rendement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
HU219056B (hu) * 1993-03-23 2001-02-28 Smithkline Beecham Biologicals Sa 3-O-Dezacilezett monofoszforil-lipid A-t tartalmazó vakcinakészítmény
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
PL346651A1 (en) 2002-02-25
EP1109574B1 (fr) 2008-04-16
PL199545B1 (pl) 2008-09-30
AU5975299A (en) 2000-04-03
HUP0104297A2 (hu) 2002-03-28
EP1109574A1 (fr) 2001-06-27
AR021798A1 (es) 2002-08-07
SI1109574T1 (sl) 2008-08-31
CA2343399C (fr) 2010-08-03
CO5090882A1 (es) 2001-10-30
IL141843A0 (en) 2002-03-10
DK1109574T3 (da) 2008-06-30
PT1109574E (pt) 2008-06-12
GB9819898D0 (en) 1998-11-04
JP2002524532A (ja) 2002-08-06
DE69938555D1 (de) 2008-05-29
CY1108147T1 (el) 2014-02-12
CZ302808B6 (cs) 2011-11-23
AU744989B2 (en) 2002-03-07
CA2343399A1 (fr) 2000-03-23
ZA200101987B (en) 2002-05-09
CN101130070A (zh) 2008-02-27
CZ2001887A3 (cs) 2001-10-17
ES2304068T3 (es) 2008-09-01
NO20011193L (no) 2001-05-09
ATE392214T1 (de) 2008-05-15
CN1325311A (zh) 2001-12-05
TWI225790B (en) 2005-01-01
NZ510425A (en) 2003-04-29
NO20011193D0 (no) 2001-03-08
DE69938555T2 (de) 2009-06-10
KR20010075049A (ko) 2001-08-09
HUP0104297A3 (en) 2004-10-28
WO2000015255A1 (fr) 2000-03-23
NO329522B1 (no) 2010-11-01
TR200100948T2 (tr) 2001-07-23
MY122216A (en) 2006-03-31
BR9913630A (pt) 2001-05-22
KR100777896B1 (ko) 2007-11-27

Similar Documents

Publication Publication Date Title
IL137294A0 (en) Antibodies against human cd40
IL158107A0 (en) Human papillomaviruses vaccine
HUP0103976A3 (en) Novel methods for therapeutic vaccination
IL140094A0 (en) Vaccine
PL346651A1 (en) Vaccine against sexually transmitted diseases
PL344519A1 (en) Vaccine
SI1117421T1 (en) Methods for therapeutic vaccination
GB9820956D0 (en) Vaccine
GB9807805D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9806765D0 (en) Vaccine
GB9802544D0 (en) Vaccine
GB9822709D0 (en) Vaccine
GB9822703D0 (en) Vaccine
GB9812773D0 (en) Vaccine
GB9809958D0 (en) Vaccine
GB9805961D0 (en) Vaccine
GB9807933D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9822712D0 (en) Vaccine
GB9805960D0 (en) Vaccine
GB9805958D0 (en) Vaccine
GB9802650D0 (en) Vaccine
GB9828035D0 (en) Vaccine
GB9802543D0 (en) Vaccine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130908